Breaking News

Sygnature Discovery and RenaSci Establish Strategic Alliance

Partnership to focus on metabolic and CNS disorders

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sygnature Discovery and RenaSci have inked a deal to provide an integrated service to accelerate client projects in metabolic and CNS disorders from discovery into development. Sygnature undertakes integrated drug discovery projects for pharmaceutical and biotechnology companies worldwide, from target validation to development candidate. RenaSci provides an integrated blend of consultancy and experimental services to the global pharmaceutical industry to help maximize research productivity an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters